GL1X · GenesisL1 explorer

Research workbench

A potent peptidomimetic inhibitor of botulinum neurotoxin serotype a has a very different conformation than snap-25 substrate

Analyse A potent peptidomimetic inhibitor of botulinum neurotoxin serotype a has a very… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3DS9
Type
protein
Length
405 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Botulinum neurotoxin type a; Octapeptide I1 inhibitor
EC
3.4.24.69
UniProt
A5HZZ9
Ligands
ZN, NI
Pockets
4 · best druggability 0.51

Structure

x-ray diffraction · 2 distinct chains · 32% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABotulinum neurotoxin type a (EC 3.4.24.69)protein39832% helix, 18% strandA5HZZ9
BOctapeptide I1 inhibitorprotein757% helix, 0% strand—

Ligands and binding sites

  • ZN · Zinc ion · metal · chains A, B
  • NI · Nickel (II) ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11580.510.7923empty
2750.470.8322empty
31210.390.7425empty
4560.300.7512empty

Interfaces

1 interface between chains.

  • A–B · 767 Ų buried · 18 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 modified (nonstandard).

Compared structures

  • 3DS9 · A potent peptidomimetic inhibitor of botulinum neurotoxin serotype A has a very different… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.